WORK MEDICAL TECHNOLOGY GR-A (WOK) Fundamental Analysis & Valuation

NASDAQ:WOK • KYG9767H1258

Current stock price

1.165 USD
-0.03 (-2.92%)
At close:
1.1748 USD
+0.01 (+0.84%)
After Hours:

This WOK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. WOK Profitability Analysis

1.1 Basic Checks

  • WOK had negative earnings in the past year.
  • WOK had a positive operating cash flow in the past year.
  • In multiple years WOK reported negative net income over the last 5 years.
  • In multiple years WOK reported negative operating cash flow during the last 5 years.
WOK Yearly Net Income VS EBIT VS OCF VS FCFWOK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 5M -5M -10M

1.2 Ratios

  • WOK has a better Return On Assets (-3.23%) than 69.52% of its industry peers.
  • The Return On Equity of WOK (-5.83%) is better than 70.05% of its industry peers.
Industry RankSector Rank
ROA -3.23%
ROE -5.83%
ROIC N/A
ROA(3y)-4.17%
ROA(5y)2.07%
ROE(3y)-10.4%
ROE(5y)7.36%
ROIC(3y)N/A
ROIC(5y)N/A
WOK Yearly ROA, ROE, ROICWOK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • WOK's Gross Margin of 23.83% is on the low side compared to the rest of the industry. WOK is outperformed by 78.61% of its industry peers.
  • In the last couple of years the Gross Margin of WOK has grown nicely.
  • WOK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.03%
GM growth 5YN/A
WOK Yearly Profit, Operating, Gross MarginsWOK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. WOK Health Analysis

2.1 Basic Checks

  • WOK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, WOK has more shares outstanding
  • WOK has a better debt/assets ratio than last year.
WOK Yearly Shares OutstandingWOK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 20K 40K 60K 80K
WOK Yearly Total Debt VS Total AssetsWOK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of 0.69, we must say that WOK is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of WOK (0.69) is comparable to the rest of the industry.
  • The Debt to FCF ratio of WOK is 1.32, which is an excellent value as it means it would take WOK, only 1.32 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of WOK (1.32) is better than 89.30% of its industry peers.
  • WOK has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
  • WOK's Debt to Equity ratio of 0.35 is in line compared to the rest of the industry. WOK outperforms 46.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.32
Altman-Z 0.69
ROIC/WACCN/A
WACC5.84%
WOK Yearly LT Debt VS Equity VS FCFWOK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 5M -5M 10M -10M 15M

2.3 Liquidity

  • A Current Ratio of 1.71 indicates that WOK should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.71, WOK is doing worse than 71.66% of the companies in the same industry.
  • A Quick Ratio of 1.50 indicates that WOK should not have too much problems paying its short term obligations.
  • The Quick ratio of WOK (1.50) is worse than 62.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.5
WOK Yearly Current Assets VS Current LiabilitesWOK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. WOK Growth Analysis

3.1 Past

  • WOK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.10%, which is quite impressive.
  • Looking at the last year, WOK shows a very negative growth in Revenue. The Revenue has decreased by -14.38% in the last year.
  • Measured over the past years, WOK shows a very negative growth in Revenue. The Revenue has been decreasing by -20.65% on average per year.
EPS 1Y (TTM)91.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.35%
Revenue 1Y (TTM)-14.38%
Revenue growth 3Y-20.65%
Revenue growth 5YN/A
Sales Q2Q%-14.35%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WOK Yearly Revenue VS EstimatesWOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

Find the best growth stocksShow best growing peers

2

4. WOK Valuation Analysis

4.1 Price/Earnings Ratio

  • WOK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WOK Price Earnings VS Forward Price EarningsWOK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of WOK indicates a rather cheap valuation: WOK is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.42
EV/EBITDA N/A
WOK Per share dataWOK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150 -200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. WOK Dividend Analysis

5.1 Amount

  • No dividends for WOK!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WOK Fundamentals: All Metrics, Ratios and Statistics

WORK MEDICAL TECHNOLOGY GR-A

NASDAQ:WOK (4/21/2026, 8:18:44 PM)

After market: 1.1748 +0.01 (+0.84%)

1.165

-0.03 (-2.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-30
Earnings (Next)N/A
Inst Owners0.16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.00M
Revenue(TTM)9.85M
Net Income(TTM)-1.07M
AnalystsN/A
Price TargetN/A
Short Float %5.16%
Short Ratio0.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF 0.42
P/OCF 0.32
P/B 0.11
P/tB 0.12
EV/EBITDA N/A
EPS(TTM)-240.47
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.81
FCFY240.88%
OCF(TTM)3.63
OCFY311.62%
SpS5.73
BVpS10.66
TBVpS10.1
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -3.23%
ROE -5.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.83%
FCFM 48.99%
ROA(3y)-4.17%
ROA(5y)2.07%
ROE(3y)-10.4%
ROE(5y)7.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.03%
GM growth 5YN/A
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.32
Debt/EBITDA N/A
Cap/Depr 153.56%
Cap/Sales 14.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.5
Altman-Z 0.69
F-Score5
WACC5.84%
ROIC/WACCN/A
Cap/Depr(3y)282.11%
Cap/Depr(5y)181.91%
Cap/Sales(3y)33.05%
Cap/Sales(5y)21.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.35%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.38%
Revenue growth 3Y-20.65%
Revenue growth 5YN/A
Sales Q2Q%-14.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y142.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y380.25%
OCF growth 3YN/A
OCF growth 5YN/A

WORK MEDICAL TECHNOLOGY GR-A / WOK Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for WORK MEDICAL TECHNOLOGY GR-A?

ChartMill assigns a fundamental rating of 2 / 10 to WOK.


Can you provide the valuation status for WORK MEDICAL TECHNOLOGY GR-A?

ChartMill assigns a valuation rating of 2 / 10 to WORK MEDICAL TECHNOLOGY GR-A (WOK). This can be considered as Overvalued.


Can you provide the profitability details for WORK MEDICAL TECHNOLOGY GR-A?

WORK MEDICAL TECHNOLOGY GR-A (WOK) has a profitability rating of 2 / 10.